ConductScience.org, home

Paper366138

Levamisole in rheumatoid arthritis--a multivariate analysis of a multicentric study.

Lewi PJ and 1 other. J Rheumatol Suppl, 1978. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Levamisole in rheumatoid arthritis--a multivariate analysis of a multicentric study. Papers, record 366138. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/366138

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Levamisole in rheumatoid arthritis--a multivariate analysis of a multicentric study.
PubMed
Journal
J Rheumatol Suppl
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.18
iCite
Revised in PubMed
2013-11-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lewi PJP J
2Symoens JJ

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arthritis, RheumatoidMajor topic
LevamisoleMajor topic
Statistics as TopicMajor topic
Belgium
Clinical Trials as Topic
Double-Blind Method
Humans
Placebos

Source PubMed

Download CSV of topics

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
7515770Alteration in lymphocyte phenotype associated with administration of adjuvant levamisole and 5-fluorouracil.Cancer Immunol Immunother1994https://conductscience.org/library/papers/7515770PubMed
7041831Levamisole in rheumatoid arthritis. Final report on a randomised double-blind study comparing a single weekly dose of levamisole with placebo. Multicentre Study Group.Ann Rheum Dis1982https://conductscience.org/library/papers/7041831PubMed
7018409Double-blind trial of dapsone against placebo in the treatment of rheumatoid arthritis.Ann Rheum Dis1981https://conductscience.org/library/papers/7018409PubMed
6751241Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis.Ann Rheum Dis1982https://conductscience.org/library/papers/6751241PubMed
3041924A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.Ann Rheum Dis1988https://conductscience.org/library/papers/3041924PubMed
2261735Follow-up with OM-8980 after a double-blind study of OM-8980 and auranofin in rheumatoid arthritis.Clin Rheumatol1990https://conductscience.org/library/papers/2261735PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/366138

GET https://conductscience.org/api/papers/v1/366138/authors